DUBAI – Shanghai Renji Hospital has positioned China at the forefront of global medical technology innovation with a groundbreaking showcase at the World Health Expo Dubai 2026, which commenced on February 9, 2026. The prestigious institution, affiliated with Shanghai Jiao Tong University School of Medicine, introduced its comprehensive “Renji Smart Hospital Solution V1.0” to the international community for the first time.
The integrated platform represents a paradigm shift in healthcare delivery, featuring intelligent operating theaters, AI-enhanced intensive care units, smart ward systems, and a sophisticated internet hospital framework. This holistic approach establishes a new benchmark for patient-centered care powered by artificial intelligence and digital transformation.
A standout innovation capturing significant attention is the “AI Doctor Assistant” (AIDA), an advanced specialist large language model and clinical decision-making platform. Developed through analysis of over 14 million service interactions and enriched by clinical data from Renji’s internet hospital and expert physicians, AIDA currently supports diagnostic and treatment processes across 18 medical specialties.
Academician Xia Qiang, President of Renji Hospital and member of the Chinese Academy of Engineering, emphasized the global dimension of modern healthcare during his presentation. “Contemporary medical advancement transcends national boundaries,” he stated. “It encompasses not only therapeutic interventions but equally importantly, the shared advancement of technological capabilities and the global extension of human healthspan.”
In a strategic move to enhance international medical collaboration, Renji Hospital formalized a partnership with UK-based private healthcare provider HarleyDoc. The agreement establishes a bidirectional cross-border medical channel that will facilitate international patient access to Shanghai’s advanced medical treatments, particularly in reproductive medicine and complex surgical procedures.
Vice President Sun Yun elaborated on the collaboration’s operational framework: “This initiative will enable overseas patients to receive cutting-edge treatments in Shanghai, with postoperative care managed through our remote monitoring platforms and AI-supported follow-up systems, effectively creating a seamless transnational healthcare continuum.”